Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Khoury · SciRah

Researcher profile · Semantic Scholar

J. Khoury

Share profile

J. Khoury — researcher profile on SciRah

h-index: 60
Works: 481
Citations: 19K

Most-cited papers

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
J. Khoury, É. Solary, O. Abla, Yassmine M. N. Akkari +58 more
2022Leukemia3,838 citations Open access
Semantic Scholar
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
R. Alaggio, Catalina Amador, I. Anagnostopoulos, A. Attygalle +79 more
2022Leukemia3,579 citations Open access
Semantic Scholar
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial.
E. Jabbour, N. Short, N. Jain, Xuelin Huang +23 more
2022The Lancet Haematology194 citations
Semantic Scholar
High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse
N. Short, H. Kantarjian, F. Ravandi, M. Konopleva +21 more
2022Blood Advances122 citations Open access
Semantic Scholar
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
E. Jabbour, N. Short, J. Senapati, N. Jain +16 more
2023The Lancet Haematology116 citations
Semantic Scholar
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)
W. Fiskus, Steffen Boettcher, N. Daver, Christopher P. Mill +13 more
2022Blood Cancer Journal115 citations Open access
Semantic Scholar
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia
Mehrnoosh Tashakori, T. Kadia, S. Loghavi, N. Daver +14 more
2022Blood99 citations Open access
Semantic Scholar
Effective therapy of AML with RUNX1 mutation by co-treatment with inhibitors of protein translation and BCL2.
Christopher P. Mill, W. Fiskus, C. Dinardo, Christine E. Birdwell +13 more
2021Blood76 citations Open access
Semantic Scholar
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
N. Jain, J. Senapati, B. Thakral, A. Ferrajoli +22 more
2022Blood Advances75 citations Open access
Semantic Scholar
Prognostic Factors for Progression in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Complete Molecular Response Within 3 Months of Therapy With Tyrosine Kinase Inhibitors
K. Sasaki, H. Kantarjian, N. Short, Bachar Samra +20 more
2021Cancer75 citations
Semantic Scholar
Activity of menin inhibitor ziftomenib (KO-539) as monotherapy or in combinations against AML cells with MLL1 rearrangement or mutant NPM1
W. Fiskus, N. Daver, Steffen Boettcher, Christopher P. Mill +12 more
2022Leukemia72 citations Open access
Semantic Scholar
Outcome of T‐cell acute lymphoblastic leukemia/lymphoma: Focus on near‐ETP phenotype and differential impact of nelarabine
K. Morita, N. Jain, H. Kantarjian, Koichi Takahashi +12 more
2021American journal of hematology/oncology72 citations Open access
Semantic Scholar
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS
C. Wai, Shangying Chen, T. Phyu, S. Fan +31 more
2022Haematologica71 citations Open access
Semantic Scholar
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
R. Alaggio, Catalina Amador, Ioannis Anagnostopoulos, A. Attygalle +81 more
2023Leukemia61 citations Open access
Semantic Scholar
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience
Guillaume Richard-Carpentier, H. Kantarjian, G. Tang, C. Yin +15 more
2021Blood Advances60 citations Open access
Semantic Scholar
Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
Sarah A. Bannon, M. Routbort, G. Montalban-Bravo, R. Mehta +21 more
2021Frontiers in Oncology59 citations Open access
Semantic Scholar
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: Position on Standards of Care and Areas of Need.
N. Pemmaraju, H. Kantarjian, K. Sweet, Eunice S. Wang +56 more
2022Blood48 citations Open access
Semantic Scholar
A Multi-Center Clinical Study to Harvest and Characterize Circulating Tumor Cells from Patients with Metastatic Breast Cancer Using the Parsortix® PC1 System
E. Cohen, G. Jayachandran, R. Moore, M. Cristofanilli +12 more
2022Cancers45 citations Open access
Semantic Scholar
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients
M. Khanlari, C. Yin, Koichi Takahashi, C. Lachowiez +9 more
2022Leukemia44 citations
Semantic Scholar
Flow Cytometric Immunophenotypic Alterations of Persistent Clonal Hematopoiesis in Remission Bone Marrows of Patients with NPM1-Mutated Acute Myeloid Leukemia
S. Loghavi, C. Dinardo, Ken Furudate, Koichi Takahashi +16 more
2021British Journal of Haematology43 citations Open access
Semantic Scholar
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm
Wei Wang, Jie Xu, J. Khoury, N. Pemmaraju +10 more
2022Cancers42 citations Open access
Semantic Scholar
Central Nervous System Involvement in Blastic Plasmacytoid Dendritic Cell Neoplasm.
N. Pemmaraju, N. Wilson, J. Khoury, N. Jain +9 more
2021Blood40 citations
Semantic Scholar
Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD
N. Pemmaraju, N. Wilson, G. Garcia-Manero, K. Sasaki +12 more
2022Blood Advances34 citations Open access
Semantic Scholar
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C. Yin, N. Pemmaraju, M. You, Shao-Ying Li +8 more
2021Cancers34 citations Open access
Semantic Scholar
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
W. Fiskus, Christopher P. Mill, Behnam Nabet, D. Perera +23 more
2021Blood Cancer Journal33 citations Open access
Semantic Scholar
Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
Hong Fang, Sa A. Wang, J. Khoury, S. El Hussein +11 more
2022Haematologica31 citations Open access
Semantic Scholar
Cyclin D1 expression in Rosai-Dorfman disease: A near constant finding that is not invariably associated with MAPK/ERK pathway activation.
S. Garces, L. Medeiros, M. Marques-Piubelli, S. A. Coelho Siqueira +13 more
2022Human Pathology31 citations
Semantic Scholar
Prediction of survival with intensive chemotherapy in acute myeloid leukemia
K. Sasaki, F. Ravandi, T. Kadia, C. Dinardo +14 more
2022American journal of hematology/oncology28 citations
Semantic Scholar
Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
S. El Hussein, H. Chifotides, J. Khoury, S. Verstovsek +1 more
2022Cancers27 citations Open access
Semantic Scholar
BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma
W. Fiskus, Christopher P. Mill, D. Perera, Christine E. Birdwell +14 more
2021Leukemia27 citations Open access
Semantic Scholar
AXL/MERTK inhibitor ONO-7475 potently synergizes with venetoclax and overcomes venetoclax resistance to kill F LT 3-ITD acute myeloid leukemia
S. Post, Hua-Xian Ma, P. Malaney, Xiao-Rui Zhang +13 more
2021Haematologica27 citations Open access
Semantic Scholar
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
N. Wilson, M. Konopleva, J. Khoury, N. Pemmaraju
2021Clinical Lymphoma, Myeloma & Leukemia26 citations
Semantic Scholar
Improved outcomes among newly diagnosed patients with FMS-like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification
P. Reville, K. Sasaki, H. Kantarjian, N. Daver +14 more
2022American journal of hematology/oncology25 citations Open access
Semantic Scholar
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
J. Senapati, M. Muftuoglu, J. Ishizawa, H. Abbas +20 more
2023Blood Cancer Journal24 citations Open access
Semantic Scholar
Venetoclax, Obinutuzumab and Atezolizumab (PD-L1 Checkpoint Inhibitor) for Treatment for Patients with Richter Transformation
N. Jain, A. Ferrajoli, P. Thompson, M. Konopleva +16 more
2021Blood24 citations Open access
Semantic Scholar
Potential Biomarkers for Treatment Response to the BCL-2 Inhibitor Venetoclax: State of the Art and Future Directions
Haneen T Salah, C. Dinardo, M. Konopleva, J. Khoury
2021Cancers22 citations Open access
Semantic Scholar
TAM kinases as regulators of cell death.
S. Post, M. Andreeff, Courtney Dinardo, J. Khoury +1 more
2021Biochimica et biophysica acta. Molecular cell research22 citations Open access
Semantic Scholar
Hyper-CVAD Plus Ofatumumab Versus Hyper-CVAD Plus/Minus Rituximab as Frontline Therapy for Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Propensity Score Analysis
K. Sasaki, H. Kantarjian, K. Morita, N. Short +16 more
2021Cancer20 citations Open access
Semantic Scholar
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse
Bachar Samra, J. Khoury, K. Morita, F. Ravandi +7 more
2021Blood Advances18 citations Open access
Semantic Scholar
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
S. El Hussein, L. Medeiros, Kirill A. Lyapichev, Hong Fang +21 more
2023Pathology (Sydney)17 citations Open access
Semantic Scholar
CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights.
N. Pemmaraju, N. Wilson, J. Senapati, M. Economides +13 more
2022Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis17 citations Open access
Semantic Scholar
3q26.2/MECOM Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features
Zhen-Ya Tang, Wen Wang, Su Yang, Hanadi El Achi +13 more
2023Cancers16 citations Open access
Semantic Scholar
Allogeneic Cord Blood T Regulatory Cells can Resolve Lung Inflammation
M. Lyu, Meixian Huang, K. Zeng, Li Li +8 more
2022Cytotherapy16 citations
Semantic Scholar
Chronic Lymphocytic Leukemia Progression Diagnosis with Intrinsic Cellular Patterns via Unsupervised Clustering
Pingjun Chen, S. El Hussein, Fuyong Xing, M. Aminu +7 more
2022Cancers16 citations Open access
Semantic Scholar
Artificial intelligence-assisted mapping of proliferation centers allows the distinction of accelerated phase from large cell transformation in chronic lymphocytic leukemia
S. El Hussein, Pingjun Chen, L. Medeiros, J. Hazle +2 more
2022Modern Pathology14 citations Open access
Semantic Scholar
Development of TP53 Mutations Over the Course of Therapy for Acute Myeloid Leukemia
Y. Alwash, J. Khoury, Mehrnoosh Tashakori, R. Kanagal-Shamanna +13 more
2021American journal of hematology/oncology14 citations Open access
Semantic Scholar
B-prolymphocytic leukemia: Is it time to retire this entity?
S. El Hussein, J. Khoury, L. Medeiros
2021Annals of Diagnostic Pathology13 citations
Semantic Scholar
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant
S. El Hussein, C. Dinardo, Koichi Takahashi, J. Khoury +12 more
2022Bone Marrow Transplantation12 citations
Semantic Scholar
B‐cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T‐cell precursor acute lymphoblastic leukaemia/lymphoma (ETP‐ALL/LBL) from other subtypes of T‐cell ALL/LBL
Hong Fang, Wei Wang, S. El Hussein, K. Morita +6 more
2021British Journal of Haematology12 citations
Semantic Scholar
TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm
Hannah C. Beird, C. Yin, J. Khoury, S. Pierce +7 more
2023Blood Advances11 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Daver×20
Invite
N. Daver — researcher profile on SciRah
T. Kadia×19
Invite
T. Kadia — researcher profile on SciRah
H. Kantarjian×18
Invite
H. Kantarjian — researcher profile on SciRah
F. Ravandi×18
Invite
F. Ravandi — researcher profile on SciRah

×18

Invite

M. Konopleva — researcher profile on SciRah

Invite

E. Jabbour — researcher profile on SciRah

Invite

C. Dinardo — researcher profile on SciRah

Invite

N. Jain — researcher profile on SciRah

N. Pemmaraju×15

Invite

N. Pemmaraju — researcher profile on SciRah

Invite

N. Short — researcher profile on SciRah

Koichi Takahashi×14

Invite

Koichi Takahashi — researcher profile on SciRah

G. Garcia-Manero×13

Invite

G. Garcia-Manero — researcher profile on SciRah